Atea Pharmaceuticals, Inc. financial data

Symbol
AVIR on Nasdaq
Industry
Pharmaceutical Preparations
Location
225 Franklin Street, Suite 2100, Boston, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.17 K % -41.6%
Debt-to-equity 6.17 % +54.2%
Return On Equity -29.2 % -72.4%
Return On Assets -27.5 % -68.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 84.2 M shares +0.99%
Common Stock, Shares, Outstanding 84.2 M shares +0.99%
Entity Public Float 284 M USD -47.2%
Common Stock, Value, Issued 84 K USD +1.21%
Weighted Average Number of Shares Outstanding, Basic 83.9 M shares +0.7%
Weighted Average Number of Shares Outstanding, Diluted 83.9 M shares +0.7%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 143 M USD +75.8%
General and Administrative Expense 49.5 M USD +1.53%
Operating Income (Loss) -192 M USD -47.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -163 M USD -44.3%
Income Tax Expense (Benefit) 1.05 M USD +17.3%
Net Income (Loss) Attributable to Parent -164 M USD -49.7%
Earnings Per Share, Basic -1.95 USD/shares -48.9%
Earnings Per Share, Diluted -1.95 USD/shares -48.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 161 M USD -12.2%
Cash, Cash Equivalents, and Short-term Investments 542 M USD -12.7%
Accounts Receivable, after Allowance for Credit Loss, Current 4.51 M USD
Assets, Current 549 M USD -13.2%
Property, Plant and Equipment, Net 1.19 M USD -26%
Operating Lease, Right-of-Use Asset 1.68 M USD -25.2%
Other Assets, Noncurrent 1.4 M USD -17.4%
Assets 553 M USD -13.3%
Accounts Payable, Current 21.1 M USD +2920%
Employee-related Liabilities, Current 2.33 M USD -2.79%
Liabilities, Current 41.3 M USD +234%
Accrued Income Taxes, Noncurrent 5.9 M USD +9.85%
Operating Lease, Liability, Noncurrent 1.45 M USD -34.8%
Liabilities 48.7 M USD +144%
Accumulated Other Comprehensive Income (Loss), Net of Tax -181 K USD +41%
Retained Earnings (Accumulated Deficit) -259 M USD -172%
Stockholders' Equity Attributable to Parent 504 M USD -18.4%
Liabilities and Equity 553 M USD -13.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -39.9 M USD -33.6%
Net Cash Provided by (Used in) Financing Activities 150 K USD -9.09%
Net Cash Provided by (Used in) Investing Activities -44 K USD
Common Stock, Shares Authorized 300 M shares 0%
Common Stock, Shares, Issued 84.2 M shares +0.99%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 17.1 M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 161 M USD -12.3%
Deferred Tax Assets, Valuation Allowance 74.2 M USD +80.2%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 74.2 M USD +80.2%
Operating Lease, Liability 2.21 M USD -24.8%
Payments to Acquire Property, Plant, and Equipment 1.94 M USD +48475%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -164 M USD -49.2%
Lessee, Operating Lease, Liability, to be Paid 2.31 M USD -25.9%
Property, Plant and Equipment, Gross 1.98 M USD 0%
Operating Lease, Liability, Current 769 K USD +5.34%
Lessee, Operating Lease, Liability, to be Paid, Year Two 855 K USD +2.03%
Lessee, Operating Lease, Liability, to be Paid, Year One 838 K USD +2.07%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 95 K USD -45.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 855 K USD +2.03%
Deferred Tax Assets, Operating Loss Carryforwards 9.39 M USD +67.9%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) -3.83 M USD -163%
Preferred Stock, Shares Authorized 10 M shares 0%
Unrecognized Tax Benefits 5.76 M USD +9.57%
Lessee, Operating Lease, Liability, to be Paid, Year Four 855 K USD +2.03%
Additional Paid in Capital 763 M USD +6.97%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 49.5 M USD +3.97%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%